- Home
- PIRS vs AIEV Comparison
PIRS vs AIEV Comparison
Compare PIRS & AIEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PIRS
- AIEV
- Stock Information
- Founded
- PIRS 2001
- AIEV 2011
- Country
- PIRS United States
- AIEV United States
- Employees
- PIRS N/A
- AIEV N/A
- Industry
- PIRS Biotechnology: Pharmaceutical Preparations
- AIEV Blank Checks
- Sector
- PIRS Health Care
- AIEV Finance
- Exchange
- PIRS Nasdaq
- AIEV Nasdaq
- Market Cap
- PIRS 22.4M
- AIEV 25.8M
- IPO Year
- PIRS N/A
- AIEV N/A
- Fundamental
- Price
- PIRS $15.93
- AIEV $0.29
- Analyst Decision
- PIRS
- AIEV
- Analyst Count
- PIRS 0
- AIEV 0
- Target Price
- PIRS N/A
- AIEV N/A
- AVG Volume (30 Days)
- PIRS 37.6K
- AIEV 116.1K
- Earning Date
- PIRS 11-13-2024
- AIEV 11-14-2024
- Dividend Yield
- PIRS N/A
- AIEV N/A
- EPS Growth
- PIRS N/A
- AIEV N/A
- EPS
- PIRS N/A
- AIEV N/A
- Revenue
- PIRS $1,352,000.00
- AIEV N/A
- Revenue This Year
- PIRS N/A
- AIEV N/A
- Revenue Next Year
- PIRS N/A
- AIEV N/A
- P/E Ratio
- PIRS N/A
- AIEV N/A
- Revenue Growth
- PIRS N/A
- AIEV N/A
- 52 Week Low
- PIRS $6.20
- AIEV $0.27
- 52 Week High
- PIRS $22.32
- AIEV $12.12
- Technical
- Relative Strength Index (RSI)
- PIRS 43.29
- AIEV N/A
- Support Level
- PIRS $15.15
- AIEV N/A
- Resistance Level
- PIRS $16.97
- AIEV N/A
- Average True Range (ATR)
- PIRS 0.72
- AIEV 0.00
- MACD
- PIRS -0.08
- AIEV 0.00
- Stochastic Oscillator
- PIRS 30.75
- AIEV 0.00
About PIRS Pieris Pharmaceuticals Inc.
Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store, and transport a wide spectrum of molecules. The Company's clinical pipeline consists of immuno-oncology, or IO, bispecifics in partnership with collaborators, including S095012 (also referred to as PRS-344) targeting PD-L1 and 4-1BB, SGN-BB228 (also referred to as PRS-346) targeting CD228 and 4-1BB, and BOS-342 (also referred to as PRS-342) targeting GPC3 and 4-1BB. Geographically, all the operations of the firm function through the region of the United States.
About AIEV Thunder Power Holdings Inc. Common Stock
Thunder Power Holdings Inc is engaged in the design and development of high-performance electric vehicles.